[Edaily Reporter Park Sun-Yeop ] BNC Korea Co, Ltd(256840)announced on the 26th that it had prevailed in the appeal hearing of a lawsuit seeking the revocation of orders—including drug recalls, disposal, and a provisional manufacturing suspension—issued against the Director of the Daegu Regional Food and Drug Safety Administration.
On the 25th, the Supreme Court dismissed the appeal filed by the Commissioner of the Daegu Regional Food and Drug Safety Administration. The defendant is responsible for the costs of the appeal.
This lawsuit was filed by BNC KOREA on November 2, 2022, against the Commissioner of the Daegu Regional Food and Drug Safety Administration, seeking the revocation of orders regarding the recall, disposal, and temporary suspension of manufacturing of its products.
The Supreme Court ruled that the appellant’s arguments did not include grounds under the Special Act on Appeal Procedures or were without merit.
The company announced that it received the ruling on the same day.
On the 25th, the Supreme Court dismissed the appeal filed by the Commissioner of the Daegu Regional Food and Drug Safety Administration. The defendant is responsible for the costs of the appeal.
This lawsuit was filed by BNC KOREA on November 2, 2022, against the Commissioner of the Daegu Regional Food and Drug Safety Administration, seeking the revocation of orders regarding the recall, disposal, and temporary suspension of manufacturing of its products.
The Supreme Court ruled that the appellant’s arguments did not include grounds under the Special Act on Appeal Procedures or were without merit.
The company announced that it received the ruling on the same day.
